Ad is loading...
MENU
TVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Travere Therapeutics (TVTX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

TVTX is expected to report earnings to fall 9.29% to -63 cents per share on March 03

Travere Therapeutics TVTX Stock Earnings Reports
Q4'24
Est.
$-0.63
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.14
Q1'24
Beat
by $2.43
Q4'23
Beat
by $2.12
The last earnings report on October 31 showed earnings per share of -69 cents, missing the estimate of -66 cents. With 995.78K shares outstanding, the current market capitalization sits at 1.69B.
View a ticker or compare two or three
TVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3611 Valley Centre Drive
Phone
+1 888 969-7879
Employees
380
Web
https://www.travere.com